The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Simplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,494
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Self-citationCOBRA: a sensitive and quantitative DNA methylation assay
Xiong, Z., & Laird, P. W. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2532 · Cited by 1,195
Signaling through the JAK/STAT pathway, recent advances and future challenges
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002) · Gene · doi:10.1016/s0378-1119(02)00398-0 · Cited by 1,154
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
Self-citationSOCS Proteins: Negative Regulators of Cytokine Signaling
Krebs, D. L., & Hilton, D. J. (2001) · STEM CELLS · doi:10.1634/stemcells.19-5-378 · Cited by 827
Understanding Ras: ‘it ain’t over ’til it’s over’
Shields, J. M., Pruitt, K., McFall, A., Shaub, A., & Der, C. J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01740-2 · Cited by 780
Bar-Sagi, D., & Hall, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00115-x · Cited by 779
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Serum levels of cytokines in chronic liver diseases
Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nölchen, B., Judmaier, G., & Huber, C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91122-k · Cited by 739
Yoshikawa, H., Matsubara, K., Qian, G.-S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., & Herman, J. G. (2001) · Nature Genetics · doi:10.1038/ng0501-29 · Cited by 722
Focus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Trikha, M., Corringham, R. E., Klein, B., & Rossi, J. (2003) · PubMed · Cited by 506
Inhibitors of Cytokine Signal Transduction
Wormald, S., & Hilton, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r300030200 · Cited by 440
The dark side of Ras: regulation of apoptosis
Cox, A. D., & Der, C. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207111 · Cited by 437
Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma
Yang, B., Guo, M., Herman, J. G., & Clark, D. P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63469-4 · Cited by 365
Identification of a Novel Ras-Regulated Proapoptotic Pathway
Khokhlatchev, A., Rabizadeh, S., Xavier, R., Nedwidek, M., Chen, T., Zhang, X.-F., Seed, B., & Avruch, J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00683-8 · Cited by 357
Niwa, Y., Kanda, H., Shikauchi, Y., Saiura, A., Matsubara, K., Kitagawa, T., Yamamoto, J., Kubo, T., & Yoshikawa, H. (2005) · Oncogene · doi:10.1038/sj.onc.1208788 · Cited by 339
Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis
Lee, S., Lee, H. J., Kim, J.-H., Lee, H.-S., Jang, J. J., & Kang, G. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63495-5 · Cited by 330
The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex
Song, M. S., Song, S. J., Ayad, N. G., Chang, J. S., Lee, J. H., Hong, H. K., Lee, H., Choi, N., Kim, J., Kim, H., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1091 · Cited by 311
Self-citationDreijerink, K., Braga, E., Kuzmin, I., Geil, L., Duh, F.-M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131216298 · Cited by 294
Activation of STAT proteins and growth control
Bromberg, J. F. (2001) · BioEssays · doi:10.1002/1521-1878(200102)23:2<161::aid-bies1023>3.0.co;2-0 · Cited by 279
Jiang, W. B., Kahn, S. M., Guillem, J. G., Lu, S. H., & Weinstein, I. B. (1989) · PubMed · Cited by 267
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Suppressors of cytokine signalling: SOCS: Review article
LARSEN, L., & RÖPKE, C. (2002) · APMIS · doi:10.1034/j.1600-0463.2002.1101201.x · Cited by 219
Arbuthnot, P., Capovilla, A., & Kew, M. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02069.x · Cited by 198
Control of microtubule stability by the RASSF1A tumor suppressor
Liu, L., Tommasi, S., Lee, D.-H., Dammann, R., & Pfeifer, G. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206984 · Cited by 193
RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor
Vos, M. D., Ellis, C. A., Elam, C., Ülkü, A. S., Taylor, B. J., & Clark, G. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300554200 · Cited by 183
K-ras mutations and RASSF1A promoter methylation in colorectal cancer
van Engeland, M., Roemen, G. M., Brink, M., Pachen, M. M., Weijenberg, M. P., de Bruïne, A. P., Arends, J.-W., van den Brandt, P. A., FPM de Goeij, A., & Herman, J. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205466 · Cited by 181
SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis
Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H., & Yoshimura, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031675 · Cited by 180
Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma
Dammann, R., Schagdarsurengin, U., Liu, L., Otto, N., Gimm, O., Dralle, H., Boehm, B. O., Pfeifer, G. P., & Hoang-Vu, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206582 · Cited by 173
Vos, M. D., Martinez, A., Elam, C., Dallol, A., Taylor, B. J., Latif, F., & Clark, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0339 · Cited by 159
Kuzmin, I., Gillespie, J. W., Protopopov, A. I., Geil, L., Dreijerink, K. M. A., Yang, Y., Vocke, C. D., Duh, F.-M. C., Zabarovsky, E. R., Minna, J. D., et al. (2002) · PubMed · Cited by 158
Hayashi, J., Aoki, H., Kajino, K., Moriyama, M., Arakawa, Y., & Hino, O. (2000) · Hepatology · doi:10.1053/jhep.2000.19343 · Cited by 147
SPAK, a STE20/SPS1-related kinase that activates the p38 pathway
Johnston, A., Naselli, G., Góñez, L. J., Martin, R. M., Harrison, L. C., & DeAizpurua, H. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203784 · Cited by 147
RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics
Dallol, A., Agathanggelou, A., Fenton, S. L., Ahmed-Choudhury, J., Hesson, L. B., Vos, M. D., Clark, G., Downward, J., Maher, E. R., & Latif, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0267 · Cited by 146
Akt (Protein Kinase B) Negatively Regulates SEK1 by Means of Protein Phosphorylation
Park, H.-S., Kim, M.-S., Huh, S.-H., Park, J., Chung, J., Kang, S. S., & Choi, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110299200 · Cited by 145
Fukushima, N., Sato, N., Sahin, F., Su, G. H., Hruban, R. H., & Goggins, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601039 · Cited by 134
Hesson, L. B., Bièche, I., Krex, D., Crinière, E., Hoang‐Xuan, K., Maher, E. R., & Latif, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207407 · Cited by 128
Santoni‐Rugiu, E., Jensen, M. R., & Thorgeirsson, S. S. (1998) · PubMed · Cited by 123
Self-citationInterspecies comparison of liver carcinogenesis: implications for cancer risk assessment
Grisham, J. W. (1997) · Carcinogenesis · doi:10.1093/carcin/18.1.59 · Cited by 118
MST1‐JNK promotes apoptosis via caspase‐dependent and independent pathways
Ura, S., Masuyama, N., Graves, J. D., & Gotoh, Y. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00439.x · Cited by 117
Lee, J., & Thorgeirsson, S. S. (2002) · Hepatology · doi:10.1053/jhep.2002.33165 · Cited by 111
Self-citationArmesilla, A. L., Williams, J. C., Buch, M. H., Pickard, A., Emerson, M., Cartwright, E. J., Oceandy, D., Vos, M. D., Gillies, S., Clark, G. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307557200 · Cited by 111
Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
Okochi, O., Hibi, K., Sakai, M., Inoue, S., Takeda, S., Kaneko, T., & Nakao, A. (2003) · PubMed · Cited by 98
Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases
Aoyama, Y., Avruch, J., & Zhang, X. (2004) · Oncogene · doi:10.1038/sj.onc.1207486 · Cited by 94
Yun, C., Cho, H., Kim, S.-J., Lee, J., Park, S. Y., Chan, G. K. T., & Cho, H. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.159.2.3 · Cited by 89
Self-citationFeo, F., Pascale, R. M., Simile, M. M., Miglio, M. R. D., Muroni, M. R., & Calvisi, D. F. (2000) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v11.i1.20 · Cited by 86
Self-citationSchuringa, J. J., Dekker, L. V., Vellenga, E., & Kruijer, W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009821200 · Cited by 84
Irimia, M., Fraga, M. F., Sánchez‐Céspedes, M., & Esteller, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207914 · Cited by 58
Nagai, H., Kim, Y. S., Konishi, N., Baba, M., Kubota, T., Yoshimura, A., & Emi, M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00244-6 · Cited by 57
Cited by
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“%) present with abnormal AFP serum levels, a fact that has been recently correlated with a molecular subclass of aggressive HCCs (S2 class, EpCAM positive) [77–79].”
BackgroundInfluentialLlovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Self-citationWilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Metadata
- Authors
- Calvisi, D. F., Ladu, S., Gorden, A., Farina, M., Conner, E. A., Lee, J., Factor, V. M., & Thorgeirsson, S. S.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 130
- Issue
- 4
- Pages
- 1117-1128
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2067224679
- Cited by
- 710
- References
- 53
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.